419 related articles for article (PubMed ID: 26600217)
61. The role of innate immunity in chronic hepatitis C viral infection.
Gale M
Gastroenterol Hepatol (N Y); 2007 Sep; 3(9):683-4. PubMed ID: 21960879
[No Abstract] [Full Text] [Related]
62. Hepatitis A: Natural history, immunopathogenesis, and outcome.
Phan C; Hollinger FB
Clin Liver Dis (Hoboken); 2013 Dec; 2(6):231-234. PubMed ID: 30992869
[No Abstract] [Full Text] [Related]
63. Advances in Hepatitis C Virus Treatment.
Lichtenstein GR
Gastroenterol Hepatol (N Y); 2015 Jul; 11(7):432. PubMed ID: 27118939
[No Abstract] [Full Text] [Related]
64. [Not Available].
Arerugi; 2021; 70(5):394-395. PubMed ID: 34275997
[No Abstract] [Full Text] [Related]
65. Hepatitis C virus: A global view.
Mohamed AA; Elbedewy TA; El-Serafy M; El-Toukhy N; Ahmed W; Ali El Din Z
World J Hepatol; 2015 Nov; 7(26):2676-80. PubMed ID: 26609344
[TBL] [Abstract][Full Text] [Related]
66. Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants.
Sepulveda-Crespo D; Resino S; Martinez I
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32560440
[TBL] [Abstract][Full Text] [Related]
67. Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection.
Tsimafeyeu I; Gafanov R; Protsenko S; Semenova A; Oganesyan A; Nurgaliyev N; Krasny S; Bondarenko A; Safina S; Zakurdaeva K
Cancer Immunol Immunother; 2020 Jun; 69(6):983-988. PubMed ID: 32078017
[TBL] [Abstract][Full Text] [Related]
68. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.
Chigbu DI; Loonawat R; Sehgal M; Patel D; Jain P
Cells; 2019 Apr; 8(4):. PubMed ID: 31027278
[TBL] [Abstract][Full Text] [Related]
69. Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine.
Ghareeb DA; Elwakeel EH; Khalil R; Aziz MS; El Demellawy MA
BMC Complement Altern Med; 2016 Aug; 16(1):325. PubMed ID: 27577059
[TBL] [Abstract][Full Text] [Related]
70. HCV immunopathogenesis: virus-induced strategies against host immunity.
Szabo G; Dolganiuc A
Clin Liver Dis; 2006 Nov; 10(4):753-71. PubMed ID: 17164116
[TBL] [Abstract][Full Text] [Related]
71. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
Yang DR; Zhu HZ
World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
[TBL] [Abstract][Full Text] [Related]
72. Immunopathogenesis of Hepatitis C Virus Infection.
Kaplan DE
Gastroenterol Clin North Am; 2015 Dec; 44(4):735-60. PubMed ID: 26600217
[TBL] [Abstract][Full Text] [Related]
73. Current progress in host innate and adaptive immunity against hepatitis C virus infection.
Shi J; Li Y; Chang W; Zhang X; Wang FS
Hepatol Int; 2017 Jul; 11(4):374-383. PubMed ID: 28643186
[TBL] [Abstract][Full Text] [Related]
74. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
Bode JG; Brenndörfer ED; Häussinger D
Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
[TBL] [Abstract][Full Text] [Related]
75. A study of innate and adaptive immune responses in beta-thalassemic patients with chronic hepatitis C virus infection.
Al-Ofairi BA; Barakat AB; Ghanim Hel-D; Shehata IH; El-Sayed MH
Egypt J Immunol; 2011; 18(1):61-76. PubMed ID: 23082481
[TBL] [Abstract][Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
